Molecular Detection by PCR<<Return to Laboratory
Molecular detection of Chlamydophila pneumoniae by PCR.
- Atypical pneumonia
Bronchoalveolar lavage (BAL), nasopharyngeal and throat swabs, nasopharyngeal aspirate (NPA), sputum, lung biopsies and cerebrospinal fluid (CSF) are acceptable sample types for testing. Dry swabs will not be accepted for testing; any swabs sent must be supplied in appropriate storage medium. At least 1.0 mL of fluid sample is required for testing, and it is preferable if all samples are supplied in screw-capped tubes made of freeze-thaw and shatter-resistant plastic.
Please follow standard aseptic sampling methods for collecting specimens and ensure any tissue samples/swabs are in appropriate storage medium.
No further processing at the sending lab is required once specimens are collected according to the above instructions. It is preferable that all specimens be frozen after collection. If that’s not possible, then store at refrigeration temperature (2 – 8°C). Ensure that specimens are held at the appropriate temperature when shipped to the NML (e.g. frozen specimens shipped with dry ice, refrigerated specimens with cold packs).
Shipping of specimens shall be done by a TDG certified individual in accordance with TDG regulations. For additional information regarding classification of specimens for the purposes of shipping, consult either Part 2 Appendix 3 of the TDG Regulations or section 3.6.2 of the IATA Dangerous Goods Regulations as applicable.
For additional guidance on the transport of infectious substances in other languages, please click on the link below.
Symptoms of respiratory infection (e.g. bronchitis, atypical pneumonia) are indicative of possible C. pneumoniae infection. However it has also been associated with other disorders such as coronary artery disease, asthma, and sarcoidosis1
Completed Special Bacteriology requisition form detailing all patient information and relevant clinical information. If possible, attach lab results that have already been done at local or provincial laboratories.
If a test performed by the submitting lab produced a positive result for C. pneumoniae, it is also helpful to indicate this in the documentation including what type of test was performed.
DNA from all C. pneumoniae samples received at the NML for PCR testing is initially extracted using a commercially-available kit. Results are based upon a real-time PCR assay targeting argR, the conserved gene encoding the arginine repressor protein within C. pneumoniae.
10 calendar days. Please note that during times when large numbers of samples are received or if tests must be repeated the turnaround time may be longer.
- Thurman, K. A., Warner, A. K., Cowart, K. C., Benitez, A. J., & Winchell, J. M. (2011). Detection of Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella spp. in clinical specimens using a single-tube multiplex real-time PCR assay. Diagnostic microbiology and infectious disease, 70(1), 1-9.